The Global and Professional Direct Contracting model is going to be replaced with a new accountable care organization (ACO) model, which addresses some of the pushback there had been on the direct contracting model, said Michael Chernew, PhD.
The Global and Professional Direct Contracting model is going to be replaced with a new accountable care organization (ACO) model, which addresses some of the pushback there had been on the direct contracting model, said Michael Chernew, PhD, Leonard D. Schaeffer Professor of Health Care Policy and director of the Healthcare Markets and Regulation Lab at Harvard Medical School; chair of the Medicare Payment Advisory Commission; and co-editor-in-chief of The American Journal of Managed Care®.
Transcript:
What are the benefits of a direct contracting model? How is it supposed to address and improve outcomes?
A direct contracting model, in my view, is really just a version of the accountable care model. And in fact, you can see when they move from direct contracting over to ACO REACH, they've renamed it an ACO model, which I think in a number of ways, is more appropriate. And the advantage of this particular model, of course, is in many ways, it's a high-powered model. There's significant symmetric risk. You could have done that in any other ACO model. You could have done it, for example, in versions of MSSP [Medicare Shared Savings Program], if you made some of these changes.
So, the direct contracting piece of it, I think, is relatively minor. There are people that believe the nature of the change in the cash flow and the opening it up to some organizations will enable entities to enter that may be able to perform better than some of the traditional ACOs, and they will like some of the cash flow rules associated with that. That may end up proving to be true, I'm not sure that it will. And of course, that same expansion of the people participating, in many ways, is what has caused some of the pushback from some quarters.
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
NK Cell Therapy SNK01 Improves Cognitive Function in Alzheimer Disease for up to 11 Weeks
December 3rd 2023Among 10 patients evaluated, compared with their baseline at 1 week after receiving their final dose in the trial, 30% demonstrated clinical improvement on the Alzheimer’s disease composite score.
Read More
Health Equity and Access Weekly Roundup: December 2, 2023
December 2nd 2023The Center on Health Equity and Access highlights the most recent updates in the realm of health equity, including news, research findings, and initiatives focused on mitigating health care disparities and enhancing overall access to quality care.
Read More